The company is adding new products treating a range of issues, including HIV, hypertension and behavioral health.

The pharmacy benefit manager has removed reauthorization requirements for more than 140 drugs so far this year amid what ...

UnitedHealth stock outlook is in sharp focus as shares stay locked between $300 and $310. With Q2 earnings approaching and ...